TheStreet

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) reçoit une note moyenne de « Conserver » de la part des analystes.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Get Rating) has received a consensus recommendation of "Hold" from the ten research firms that are presently...